Page last updated: 2024-09-04

mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and Diabetes Mellitus, Type 2

mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with Diabetes Mellitus, Type 2 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Affourtit, C; Brand, MD; Jastroch, M1
Hart, JL; Leo, CH; Woodman, OL1
Champion, HC; Dugas, TR; Duranski, MR; Elrod, JW; Greer, JJ; Kevil, CG; Langston, W; Lefer, DJ; Tao, L1

Other Studies

3 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and Diabetes Mellitus, Type 2

ArticleYear
Uncoupling protein-2 attenuates glucose-stimulated insulin secretion in INS-1E insulinoma cells by lowering mitochondrial reactive oxygen species.
    Free radical biology & medicine, 2011, Mar-01, Volume: 50, Issue:5

    Topics: Animals; Antioxidants; Cell Line, Tumor; Diabetes Mellitus, Type 2; Energy Metabolism; Gene Knockdown Techniques; Glucose; Insulin; Insulin Secretion; Insulin-Secreting Cells; Ion Channels; Metalloporphyrins; Mice; Mitochondria; Mitochondrial Proteins; Rats; Reactive Oxygen Species; Uncoupling Protein 2

2011
3',4'-Dihydroxyflavonol restores endothelium-dependent relaxation in small mesenteric artery from rats with type 1 and type 2 diabetes.
    European journal of pharmacology, 2011, Jun-01, Volume: 659, Issue:2-3

    Topics: Animals; Antioxidants; Biomimetic Materials; Blood Glucose; Body Weight; Cyclic N-Oxides; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Endothelium, Vascular; Flavonols; Mesenteric Arteries; Metalloporphyrins; Microvessels; Rats; Rats, Sprague-Dawley; Spin Labels; Superoxides; Vasodilation

2011
eNOS gene therapy exacerbates hepatic ischemia-reperfusion injury in diabetes: a role for eNOS uncoupling.
    Circulation research, 2006, Jul-07, Volume: 99, Issue:1

    Topics: Animals; Biological Availability; Biopterins; Diabetes Mellitus, Type 2; Drug Synergism; Genetic Therapy; Liver; Metalloporphyrins; Mice; Mice, Inbred Strains; Mice, Transgenic; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Nitrites; Phenotype; Phosphorylation; Pterins; Reperfusion Injury; Severity of Illness Index; Tyrosine

2006